Up-regulation of NF kappa B-dependent APG gene by hepatitis B virus-encoded X antigen in hepatocellular carcinoma

DD Lu,XR Zhang,XR Cao
2003-01-01
Experimental Oncology
Abstract:Objective: To investigate the function of APG gene up-regulated by hepatitis B virus-encoded X antigen (HbxAg) in the occurrence of hepatocellular carcinoma. Methods and results: PCR select cDNA subtraction of HbxAg-positive HepG2 cells compared with HBxAg-negative HepG2 cells demonstrated the up-regulated expression of APG gene that encodes a 800 bases long transcript and a polypeptide consisting from 100 amino acid residues. In situ hybridization and immunostaining showed co-localized expression of APG and HbxAg in the liver tissue of hepatitis B carriers. Overexpression of APG protein stimulated the growth of HepG2 cells in serum-free medium, and partially protected cells from Fas-mediated killing, promoted cell growth in soft agar or tumor formation in nude mice. Introduction of the dominant negative inhibitor of nuclear factor kappaB (IkappaBalpha) into HBxAg-positive HepG2 cells decreased the levels of APG on mRNA and protein levels suggesting that its up-regulation is NFkappaB-dependent. Conclusion: HBxAg activation of NFkappaB may result in the up-regulation of APG protein that promotes growth factor-independent survival of cells and protects them against Fas-mediated killing. This factor may contribute to the persistence of infected hepatocytes during chronic infection, which is important for the later development of hepatocellular carcinoma (HCC).
What problem does this paper attempt to address?